View Document Preview and Link Open Document File Size: 404,61 KB Share Result on Facebook
Company FVIII / Grifols Biologicals Inc. / Factor VIII Deficiency 1 / VWD / Factor VIII Deficiency Alphanate / / Event FDA Phase / / Facility AHF/VWF Complex / Willebrand Factor Complex / von Willebrand Factor Complex / ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX / / IndustryTerm administration equipment / parenteral drug products / von Willebrand Disease Treatment / treatment of hemophilia / / MedicalCondition Willebrand Disease / cuts / physician von Willebrand Disease / Creutzfeldt-Jakob disease / VWF deficiency / hemophilia A / acute hemolytic anemia / chills / Hematuria / progressive hemolytic anemia / Intracranial hemorrhages / CJD / anaphylaxis / immediate hypersensitivity / VIII Deficiency / fever / severe von Willebrand Disease / severe hypersensitivity / pain / urticaria / pediatric hemophilia A / von Willebrand Disease / deficiency / thrombosis / pruritus / rash / infectious agents / joint pain / paresthesia / hemophilia / Severe Hypersensitivity Reactions Anaphylaxis / respiratory distress / / MedicalTreatment Minor Surgery / invasive procedure / bypass / major surgery / alternative therapy / invasive procedures / emergency treatment / Surgery / / Organization DOSAGE AND ADMINISTRATION For Intravenous Use Only Antihemophilic Factor / AND ADMINISTRATION For Intravenous Use Only Antihemophilic Factor / Rapid administration / DOSAGE AND ADMINISTRATION / FDA / Vasomotor Reactions Rapid administration / / Person Therapeutic Goal (Trough) / / / Position investigator / physician / Major / / Product DDAVP / Sterile Water for Injection / DDAVP® / / ProvinceOrState Alberta / / Technology pharmacokinetics / antibodies / / URL www.fda.gov/medwatch / / SocialTag 
HIGHLIGHTS OF PRESCRIBING INFORMATION